Expanding Horizons: Antibody Drug Conjugates in Non-Small Cell Lung Cancer - Episode 4
HER2-Directed Agents in NSCLC
Dr Wade Thomas Iams explains how trastuzumab deruxtecan became the standard-of-care for HER2-mutated non-small cell lung cancer.
Expanding Horizons: Antibody Drug Conjugates in Non-Small Cell Lung Cancer - Episode 4
Dr Wade Thomas Iams explains how trastuzumab deruxtecan became the standard-of-care for HER2-mutated non-small cell lung cancer.
